An inframe perforin gene deletion in familial hemophagocytic lymphohistiocytosis is associated with perforin expression

Familial hemophagocytic lymphohistiocytosis is an autosomal recessive disease of early childhood manifested by hypercytokinemia and organ infiltration of macrophages and activated lymphocytes, and it is characterized by a fulminant clinical course. The molecular mechanism underlying this disease appears to be a deregulation of apoptosis of activated T cells and macrophages. Approximately 20–40% of patients with familial hemophagocytic lymphohistiocytosis reported worldwide had a perforin gene mutation. We report herein a novel perforin variant in the homozygous state in an Omani boy who was diagnosed 44 days after birth. Sequence analysis of the perforin gene coding region revealed a 12‐base pair deletion (codon 284–287) resulting in the deletion of four amino acids in the membrane attack complex domain of the protein. This deletion maintains the reading frame of the perforin mRNA. Both parents were heterozygotes for this molecular defect. Flow‐cytometric analysis revealed intracellular perforin expression at the lower end of the normal range in the cytotoxic T cells (CD3+/CD8+) and (CD3+/CD56+) and in around 50% of the natural killer cells (CD3−/CD56+). This is an additional example of a perforin variant which is associated with a significant level of cellular perforin expression and thus confirms that drastic reduction in its expression is not a constant feature in familial hemophagocytic lymphohistiocytosis type 2. Am. J. Hematol. 78:59–63, 2005. © 2004 Wiley‐Liss, Inc.

[1]  A. Filipovich,et al.  Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis , 2004, Journal of Medical Genetics.

[2]  D. Flower,et al.  Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing , 2003, American journal of medical genetics. Part A.

[3]  R. Clementi,et al.  Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression , 2002, British journal of haematology.

[4]  A. Fischer,et al.  Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis , 2002, British journal of haematology.

[5]  H. Takada,et al.  Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan , 2002, British journal of haematology.

[6]  D. Marmer,et al.  Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. , 2002, Blood.

[7]  R. Clementi,et al.  Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis , 2001, Journal of medical genetics.

[8]  Marion E. Schneider,et al.  Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. , 2001, American journal of human genetics.

[9]  J. Wolff,et al.  Further Evidence for Genetic Heterogeneity in Familial Hemophagocytic Lymphohistiocytosis (FHLH) , 2000, Pediatric Research.

[10]  A. Fischer,et al.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis. , 1999, Science.

[11]  James C. Powers,et al.  The Human Cytotoxic T Cell Granule Serine Protease Granzyme H Has Chymotrypsin-like (Chymase) Activity and Is Taken Up into Cytoplasmic Vesicles Reminiscent of Granzyme B-containing Endosomes* , 1999, The Journal of Biological Chemistry.

[12]  R. Dufourcq-Lagelouse,et al.  Genetic basis of hemophagocytic lymphohistiocytosis syndrome (Review). , 1999, International journal of molecular medicine.

[13]  A. Fischer,et al.  Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity. , 1999, American journal of human genetics.

[14]  P. Sham,et al.  Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. , 1999, American journal of human genetics.

[15]  A. Fischer,et al.  Treatment of Familial Hemophagocytic Lymphohistiocytosis With Bone Marrow Transplantation From HLA Genetically Nonidentical Donors , 1997 .

[16]  M. Zvelebil,et al.  Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid‐binding C2 domain , 1997, The EMBO journal.

[17]  A. Fischer,et al.  Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. , 1996, Leukemia.

[18]  B. Favara Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. , 1992, Seminars in diagnostic pathology.

[19]  A. Öst,et al.  DIAGNOSTIC GUIDELINES FOR HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS , 1991 .

[20]  P. Lu,et al.  Structure and function of human perforin , 1988, Nature.

[21]  G. Leverger,et al.  Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. , 1986, The Journal of pediatrics.